isoxazoles has been researched along with Mesothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanibuchi, M; Ikuta, K; Kakiuchi, S; Kanematsu, T; Ogino, H; Sekido, Y; Sone, S; Taniguchi, T; Yamada, T; Yano, S | 1 |
| Borden, EC; Falkson, G; Simson, IW; Vorobiof, DA | 1 |
2 other study(ies) available for isoxazoles and Mesothelioma
| Article | Year |
|---|---|
Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Lysophospholipids; Mesothelioma; Pleural Neoplasms; Propionates; Receptors, Lysophosphatidic Acid | 2008 |
Phase II trial of acivicin in malignant mesothelioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Isoxazoles; Male; Mesothelioma; Middle Aged; Oxazoles; Peritoneal Neoplasms; Pleural Neoplasms | 1987 |